Cancer-free after immunotherapy treatment: Treating advanced colon cancer – targeting KRAS gene mutation by tumor-infiltrating lymphocytes (TILs) and Killer T-cells (NK) Reporter: Aviva Lev-Ari, PhD, RN   Based on By DENISE GRADY DEC. 7, 2016 Continue reading the main story http://www.nytimes.com/2016/12/07/health/cancer-immunotherapy.html?_r=0 The research involves cancer-fighting immune cells called tumor-infiltrating lymphocytes, or TILs. These are white blood … Continue reading Cancer-free after immunotherapy treatment: Treating advanced colon cancer – targeting KRAS gene mutation by tumor-infiltrating lymphocytes (TILs) and Killer T-cells (NK)